As shown in Figure 2A, wogonin can down-regulate the expression of AKT2 and enhance the sensitivity of gemcitabine to pancreatic cancer cell; As shown in Figure 3B, the differentially expressed genes for wogonin sensitization were enriched in protein kinase B (Akt) signaling. Here, AKT2 is linked to pancreatic neoplasm.